Skip to content
Search

Latest Stories

NHS Pay Review Body should focus on the pay rates of pharmacists in bands 5-8: PDA

NHS Pay Review Body should focus on the pay rates of pharmacists in bands 5-8: PDA

It also highlighted several workforce challenges that have impacted the recruitment and retention of pharmacists across all areas of pharmacy practice.    

The Pharmacists' Defence Association (PDA) has submitted evidence to the NHS Pay Review Body (PRB), emphasising on the recruitment and retention of NHS pharmacists.


It has urged the PRB to help the NHS achieve two important objectives – ensuring that pharmacists can achieve well-rewarded and the service is viewed as an appealing alternative by student pharmacists.

The PDA suggested that for the NHS to remain competitive, the PRB should focus its pay approach on employees within Bands 5-8 this year.

It recognised that the last recommendation from the PRB was a “flat rate increase” and it left those working in the above-mentioned bands feeling “unhappy”, which led to the CSP taking strike action over pay for the first time in their history.

Consequently, it recommended that this year’s recommendations should be referred to and linked to the 2018 restructuring of the Agenda for Change (AfC) pay bands.

Paul Moloney, PDA Union National Officer said: “The PDA has become increasingly concerned that the Pay Review Body receives no submission specifically related to pharmacists employed under Agenda for Change terms and conditions and we wanted to change that.

“We have therefore produced evidence to show the urgency of ensuring that pharmacists are fairly renumerated for the work they do and acknowledging that for many the purchasing power of their income has fallen over successive years.”

“While we are not arguing for special treatment for our 7,000 members in hospitals, we make a strong case for the PRB to look specifically as the pay bands our members work in and use that analysis as the driving force for this year’s recommendation to government on NHS pay,” he added.

As of 31 December 2023, the General Pharmaceutical Council (GPhC) register listed 64,104 pharmacists, with 54,119 of them located in England.

The PDA highlighted that while the number of registered pharmacists continues to grow “several workforce challenges” have impacted the recruitment and retention of pharmacists across all areas of pharmacy practice.

The workforce-related issues included chronic understaffing, sub-standard working environments, the inability to exercise their professional judgement, an absence of protected training time and experiences of racism, violence and abuse.

According to the Pharmacy Workforce Race Equality Standard (PWRES) report published by NHS England in September 2023, pharmacy team members of Black, Asian and minority ethnic origin experience more “harassment, bullying and abuse, poorer career progression and greater experience of discrimination” than White pharmacy team members.

In a survey conducted by the PDA, around 77 per cent of hospital pharmacists revealed that they were looking to change their career or employment status in the next 12-18 months, citing pressure and mental health concerns and pay as the primary issues

Other concerns were burnout, workplace pressure (not enough resources, skill mix) and dissatisfaction (lack of reward, feeling undervalued and demotivated).

A small number of respondents (four per cent) identified bullying and harassment as their main concerns.

In December 2023, the PDA carried out a separate workforce temperature check of over 2,000 pharmacists working in all areas of practice and it was found that nearly one-third of respondents were looking to leave pharmacy altogether

Approximately two-third of them were required to undertake more non-clinical work due to a lack of support staffing.

Further, the representative body of pharmacists reported that many of its members have chosen to become locum pharmacists to help manage workplace stress and poor mental health.

More For You

Omega Pharmacy in Derbyshire Finds New Owner in Just 18 Days

Omega Pharmacy

Christie & Co

Omega Pharmacy in Derbyshire sold in just 18 days

Omega Pharmacy in Derbyshire has found a new owner in less than three weeks after being put on the market.

The pharmacy was previously owned by husband-and-wife duo Manny and Poonam Rai, who decided to sell it after a short period of ownership to focus on their other pharmacy in Coventry, according to Christie & Co.

Keep ReadingShow less
DHSC announces second list of March 2025 price concessions

A price concession only applies for the month it is granted.

Getty Images

March price concessions list released; prescription charge remains unchanged

The Department of Health and Social Care (DHSC) has released a second list of price concessions for March 2025, following ongoing discussions with Community Pharmacy England (CPE) regarding medicine pricing concerns raised by pharmacy owners.

A price concession is introduced when pharmacy contractors are unable to source a drug at or below the reimbursement price set out in the Drug Tariff.

Keep ReadingShow less
AstraZeneca partners with CEPI to develop multi-specific influenza antibody

AstraZeneca-CEPI collaboration aims to increase global access to antibody-based interventions

Getty Images

AstraZeneca secures £33M CEPI funding to develop multi-specific influenza antibody

AstraZeneca has joined forces with the Coalition for Epidemic Preparedness Innovations (CEPI) to advance an innovative antibody technology that could help tackle future infectious disease outbreaks and pandemics swiftly and more affordably.

CEPI will provide up to US$43.5 million (£33.6 million) in funding to support the biopharmaceutical company in evaluating a type of antibody, known as a VHH (Variable Heavy domain of a Heavy chain -only antibody), through preclinical proof-of-concept studies and Phase 1 clinical trials.

Keep ReadingShow less
Community Pharmacy Patient Safety Group announces new vice-chair

Martin Sadr-Kazemi 's appointment follows the passing of Dr. José Moss in January 2025.

Martin Sadr-Kazemi appointed vice-chair of Community Pharmacy Patient Safety Group

The Community Pharmacy Patient Safety Group (CPPSG) has announced the appointment of Martin Sadr-Kazemi as its new vice-chair.

Martin, currently the medication safety officer and deputy superintendent pharmacist at Rowlands Pharmacy, has been an integral member of the CPPSG since its formation a decade ago, actively contributing to various initiatives.

Keep ReadingShow less
"My work benefits all across London," says ambulance pharmacy technician

Mahrukh Jaffar

Pic credit: London Ambulance Service

"My work benefits all across London," says ambulance pharmacy technician

Mahrukh Jaffar will create history when she becomes the first apprentice to become a qualified pharmacy technician through the London Ambulance Service.

Jaffar is just days away from completing her registration with the General Pharmaceutical Council.

Keep ReadingShow less